Lee Firestone
Podiatrist · Washington, DCNPI 1659370641
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,200 of the $1,717 with a category attached, or 69.9%. Supreme Orthopedic Systems, LLC accounts for 71.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $1,277 and has fallen 88.3% since, to $150 in 2025.
Across 17 payments — averaging $101.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$1K
- Bioventus LLC$156
- Amgen$146
- Stryker$63
- Innovation Technologies Inc$42
- Smith+Nephew$35
- plus $49 from 3 others
What the payments were for
- Food & beverage$51730%
- Education$1,20070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 2 | $1,227 |
| Bioventus LLC | 2 | $156 |
| Amgen(2 entities) | 3 | $146 |
| Stryker(2 entities) | 4 | $63 |
| Innovation Technologies Inc | 1 | $42 |
| Smith+Nephew | 2 | $35 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| Medline Industries LP | 1 | $19 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,717 in reported general payments places this provider in the 75th percentile of 24 podiatrist providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 12 | $269 |
| Mupirocin | 22 | $247 |
| Gabapentin | 12 | $133 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $119 |
| Allopurinol | 13 | $104 |
| Meloxicam | 23 | $46 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Washington
- Kevin JeffersonWashington$94K
- Michael StempelWashington$5K
- Nadav AvnerWashington$4K
- Farah SiddiquiWashington$2K
- Ian BeiserWashington$2K
- Kirk GeterWashington$1K
- Arnold RavickWashington$1K
- Sheldon LapsWashington$1K
- Lubrina BryantWashington$951
- James GirolamiWashington$718
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.